FAYE M JOHNSON to Quinolines
This is a "connection" page, showing publications FAYE M JOHNSON has written about Quinolines.
Connection Strength
0.135
-
Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer. Cancer Chemother Pharmacol. 2018 08; 82(2):285-298.
Score: 0.121
-
SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines. Am J Pathol. 2007 Jan; 170(1):366-76.
Score: 0.014